Synopsis
This work develops an NCE-MRA technique based on the
flow-sensitised dephasing (FSD) method but using a fast-spin echo (FSE) readout
to avoid off-resonance artifacts and allow a larger field of view. The
flow-preparation module may be velocity-sensitised, acceleration-sensitised or mixed
velocity-and-acceleration-sensitised. The
FSE readout allows these approaches to be combined with additional flow
sensitisation by ‘adaptive refocus’ which reduces the refocusing flip angle in
systole. These approaches performed well in healthy volunteers, in particular
the velocity-sensitisation and mixed-sensitisation
approaches. Adding adaptive refocus increased venous contamination and thus
reduced the arterial image quality. Future work will evaluate these methods in
patients.Purpose
The flow-sensitised dephasing (FSD) approach to
Non-Contrast-Enhanced MRA (NCE-MRA) generates 3D subtraction angiograms, suppressing flowing blood by sensitising the
signal to either velocity1–2 or acceleration3. Acceleration sensitisation
allows improved discrimination between arteries and veins3 but can be
sub-optimal in some patients with insufficiently pulsatile arterial flow4.
Previous FSD work has mostly used a balanced SSFP (bSSFP)
readout, but this causes off-resonance artifacts that reduce the usable field
of view (FoV) and
the vessel homogeneity. An alternative approach using a fast-spin echo (FSE) readout
which should eliminate these problems. An FSE readout may optionally
incorporate additional flow-related signal dephasing, e.g. by using an
‘adaptive refocus’ approach which reduces the refocusing flip angle5 during
the systolic ‘dark-blood’ acquisition.
The aim of this work is to develop an NCE-MRA technique
using an FSE readout and a flow-sensitised dephasing approach that can combine both
velocity
and acceleration sensitisation.
Methods
Following ethical approval and informed consent, the lower
legs of 10 healthy volunteers were imaged at 1.5 T (Discovery MR450, GE
Healthcare, Waukesha, WI). NCE-MRA images were acquired for each subject, using
the three different preparation modules shown in Figure 1. These acquisitions
have a large first gradient moment m1
for velocity sensitisation, a large second gradient moment m2 for acceleration sensitisation, and large m1 and m2 for mixed velocity/acceleration-sensitisation. In
each case, bright-blood (diastolic) and dark-blood (systolic) acquisitions were
interleaved.
Additionally, in 8 subjects the three NCE-MRA sequences were
repeated using adaptive refocus for added flow suppression in the systolic
phase. Also, a product NCE-MRA sequence, which uses only adaptive refocus, was
acquired for comparison.
The acquisitions used a 3D FSE readout (TE=60, TR=3RR,
FoV=40cm, acquisition matrix=320x224x40, slice thickness=2.4mm, ETL=64, ARC
acceleration factor=2, 0.5 Nex, refocus flip angle=180°, flow compensation, radial view
order, total scan time=207 heartbeats). Fat and other background signals were
suppressed using non-spectrally-selective dual inversion recovery6. However,
the product sequence instead used ASSET parallel imaging and single inversion
recovery. The refocusing flip angle was 180°
except for the systolic phase of adaptive refocus acquisitions, which used 105° (steady state). The
velocity- and acceleration-sensitisation gradients were optimised for
each subject using prior 2D
multi-phase acquisitions as scout sequences (parameters as above but 1 slice,
thickness 4–6cm, 8 phases, m1
range 46–154 nTs2/m, m2
range 2.8–9.2 nTs3/m) in a similar fashion to ref 7. The systolic trigger
delay was determined from a 2D cine phase-contrast acquisition through the
popliteal arteries (TE/TR=3.3/6.6
ms; flip angle=30°;
matrix 256×128; FoV=40x20 cm2; slice thickness=7 mm; venc=80 cm/s, 1
vps), while the diastolic delay was determined using a 2D multi-phase
single-shot FSE scout sequence (TE=78ms, TR=4RR, ASSET factor 2, slice
thickness 150 mm, 16 phases covering 80% of cardiac
cycle).
MIP images were assessed by an experienced radiologist
(blinded to sequence type and randomised within each subject) who used 5-point
Likert scales (0–4) to score arterial image quality, deep vein signal contamination
and background levels.
For demonstration purposes, example velocity-sensitised images
were acquired using both FSE and bSSFP readouts in one volunteer.
Results
The chosen flow sensitisation parameters ranged from 62–108 nTs2/m
(m1) and 3.7–6.4 nTs3/m
(m2). Example images from
one subject are shown in Fig. 2.
Boxplots
of the radiologist scores are shown in Figure 3. All images were graded as being
of diagnostic quality, with the velocity-sensitised images the best and the
mixed velocity/acceleration-sensitisation also graded highly. For all three
sequence types, the addition of adaptive refocus increased the venous
contamination levels and consequently
reduced the quality of arterial depiction.
Figure 4 compares example images acquired using FSE and
bSSFP readouts, showing the greater coverage and vessel homogeneity for FSE.
Discussion
The use of FSE for the readout offers good or excellent arterial
image quality over a larger field of view than previous FSD studies using
bSSFP, and without off-resonance artifacts. We have also demonstrated (for the
first time to our knowledge) the feasibility of combining velocity- and
acceleration-sensitisation in
a single flow preparation module, and of combining both with adaptive refocus for
further potential improvements to the flow suppression. In healthy volunteers
with normal arterial flow profiles, the separate approaches work well so (as
expected) these combinations added little benefit. We now plan to assess these
combined approaches in patients with peripheral vascular disease and less
predictable arterial flow profiles where they may prove more effective than the
separate strategies
4.
Conclusion
A 3D FSE-based flow-sensitised NCE-MRA
technique has been developed and demonstrated, with good results, in healthy
volunteers. This approach can optionally combine acceleration sensitisation and
velocity sensitisation. Future work will evaluate these approaches in patients.
Acknowledgements
We thank the Addenbrooke's Charitable Trust and the Cambridge NIHR Biomedical Research Centre for funding; and the MRIS staff for assistance with this study.References
1. Fan Z,
Sheehan J, Bi X, Liu X, Carr J, Li D.
Evaluation of Non Contrast Enhanced MRA in patients with PVD. Magn
Reson Med. 2009;62(6):1523-32.
2. Priest AN, Graves MJ, Lomas DJ.
Non-contrast-enhanced vascular magnetic resonance imaging using flow-dependent
preparation with subtraction. Magn Reson Med. 2012;67(3):628–637.
3. Priest AN, Taviani V, Graves MJ, Lomas DJ. Improved
Artery–Vein Separation with Acceleration-Dependent Preparation for
Non–Contrast-Enhanced Magnetic Resonance Angiography. Magn Reson Med. 2014;72(3):699–706.
4. N Shaida, AN Priest, TC See, AP Winterbottom, MJ Graves, DJ
Lomas. Evaluation of Non Contrast Enhanced MRA in patients with PVD. Proc Intl
Soc Mag Reson Med. 2014; 22: 3865.
5. Storey P, Atanasova IP, Lim RP, Xu J, Kim D, Chen Q, Lee
VS. Tailoring the flow sensitivity of fast spin-echo sequences for noncontrast
peripheral MR angiography. Magn Reson Med. 2010;64(4):1098-108.
6. Priest AN, Low G, Graves MJ, Lomas DJ. Non-contrast-enhanced
MR angiography of the thoracic central veins. Proc Intl Soc Mag Reson Med. 2014; 22: 2513.
7. Fan Z, Zhou X, Bi X, Dharmakumar R, Carr JC,
Li D. Determination of the optimal first-order gradient moment for
flow-sensitive dephasing magnetization-prepared 3D noncontrast MR angiography. Magn Reson Med. 2011 Apr;65(4):964–972.